Company / EPS (Basic)
Beta Bionics, Inc. EPS (Basic) History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$8.60
FY2025
5-year range
-$8.60 / -$8.31
FY2023-FY2025
Trend
-3.5%
vs FY2024
Sector context
#154 of 160
Health Care
What the data says
Among 160 Health Care companies, Beta Bionics, Inc. is in the bottom 4% for eps (basic). EPS (Basic) remained relatively stable over the past 3 years, with values between $-8.60 and $-8.31.
Based on SEC 10-K filings.
-8.60 in FY2025.
Declined from $-8.31 to $-8.60 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 160This company -$8.60 Sector average $1.57
▼
-646.3% below sector average
Key checks
Key Insights
- In FY2025, eps (basic) decreased 3.5% year-over-year.
- Ranks #154 out of 160 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$8.60 | -3.5% |
| FY2024 | -$8.31 | +0.0% |
| FY2023 | -$8.31 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026